Most Active InvestorsFind investorsPricing
Start for free
Start for free
Marshall Wace logo

Marshall Wace

Europe, England, United Kingdom, London

Description

Marshall Wace is a global asset manager that offers a diverse range of investors alternative investment solutions.

Investor Profile

Marshall Wace has backed more than 63 startups, with 10 new investments in the last 12 months alone. The firm has led 16 rounds, about 25% of its total and boasts 16 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, India, Switzerland.
  • Strong thematic focus on Biotechnology, Health Care, Financial Services.
  • Led 1 rounds in the past year.

Stage Focus

  • Series C (22%)
  • Series B (21%)
  • Post Ipo Equity (17%)
  • Series E (11%)
  • Series Unknown (8%)
  • Series D (6%)
  • Series A (5%)
  • Private Equity (5%)
  • Series F (3%)
  • Seed (2%)

Country Focus

  • United States (78%)
  • India (8%)
  • Switzerland (5%)
  • Canada (3%)
  • United Kingdom (3%)
  • Singapore (2%)
  • Israel (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Financial Services
  • Fintech
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Life Science
  • Blockchain
  • Cryptocurrency
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Marshall Wace frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 9
venBio Partners
venBio Partners
North America, California, United States, San Francisco
Co-Investments: 8
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 10
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 6
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 8
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 10
Deep Track Capital
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 6
Soleus Capital
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 8
Logos Capital
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 10
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 11

Which angels does Marshall Wace often collaborate with?

Uday Kumar Bangalore Shivaraman
Uday Kumar Bangalore Shivaraman
Asia, Karnataka, India, Bengaluru
Shared Deals: 1
PL
Pierre Lamond
North America, California, United States, Palo Alto
Shared Deals: 1
FS
Frank Slootman
North America, California, United States, Santa Clara
Shared Deals: 1
AG
Alex Gorsky
North America, New Jersey, United States, New Brunswick
Shared Deals: 1
EC
Emilie Choi
North America, California, United States, San Francisco
Shared Deals: 1
CC
Caesar Chad
North America, California, United States, San Jose
Shared Deals: 1
MS
Michael Scarpelli
North America, California, United States, San Francisco
Shared Deals: 1
BT
Belinda Termeer
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
MJ
Shared Deals: 1

What are some of recent deals done by Marshall Wace?

InspireMD

Miami, Florida, United States

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.

BiopharmaBiotechnologyHealth CareMedical Device
Post Ipo EquityJul 31, 2025
Amount Raised: $58,000,000
Rezolute

Louisville, Colorado, United States

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

BiotechnologyDiabetesHealth CareTherapeutics
Post Ipo EquityApr 23, 2025
Amount Raised: $96,900,000
Attovia Therapeutics

San Carlos, California, United States

Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series CApr 15, 2025
Amount Raised: $90,000,000
Sammaan Capital

Mumbai, Maharashtra, India

Sammaan Capital offers home loans in the affordable housing segment.

CreditFinancial ServicesLendingReal Estate
Post Ipo EquityJan 27, 2025
Amount Raised: $151,179,028
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
35Pharma

Montreal, Quebec, Canada

35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

BiopharmaBiotechnologyPharmaceutical
Series CNov 26, 2024
Amount Raised: $53,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

BiotechnologyDiabetesMedical Device
Series ENov 13, 2024
Amount Raised: $60,000,000
Inquis Medical

Redwood City, California, United States

Inquis Medical is developing thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss.

Health CareMedical
Series BNov 4, 2024
Amount Raised: $40,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Elektrofi

Boston, Massachusetts, United States

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Alternative MedicineBiotechnologyTherapeutics
Series CAug 22, 2024
Amount Raised: $112,250,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator